Literature DB >> 20585131

Clinical outcomes by methicillin-resistant Staphylococcus aureus staphylococcal cassette chromosome mec type: isolates recovered from a phase IV clinical trial of linezolid and vancomycin for complicated skin and skin structure infections.

David B Huang, Arlene Reisman, Patricia Hogan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20585131      PMCID: PMC2934975          DOI: 10.1128/AAC.00044-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  4 in total

1.  Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus.

Authors:  Kamal M F Itani; Matthew S Dryden; Helen Bhattacharyya; Mark J Kunkel; Alice M Baruch; John A Weigelt
Journal:  Am J Surg       Date:  2010-03-15       Impact factor: 2.565

2.  A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides.

Authors:  Mandy Wootton; Alasdair P MacGowan; Timothy R Walsh; Robin A Howe
Journal:  J Clin Microbiol       Date:  2006-11-15       Impact factor: 5.948

3.  Role of SCCmec type in outcome of Staphylococcus aureus bacteremia in a single medical center.

Authors:  Roopa Ganga; Kathleen Riederer; Mamta Sharma; Mohamad G Fakih; Leonard B Johnson; Stephen Shemes; Riad Khatib
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

4.  Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid.

Authors:  Rodrigo E Mendes; Helio S Sader; Lalitagauri M Deshpande; Binh An Diep; Henry F Chambers; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2009-11-25       Impact factor: 5.948

  4 in total
  1 in total

1.  The effect of staphylococcal cassette chromosome mec (SCCmec) type on clinical outcomes in methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Jennifer H Han; Paul H Edelstein; Warren B Bilker; Ebbing Lautenbach
Journal:  J Infect       Date:  2012-09-06       Impact factor: 6.072

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.